Related Experiment Video
Updated: Aug 12, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Transgenic analysis of prion diseases
1Institute of Cell and Molecular Biology, University of Edinburgh, UK.
Molecular Human Reproduction
|June 1, 1997
Summary
Prion diseases are fatal neurological disorders. Transgenic technology reveals that the prion protein (PrP) is critical for disease development and transmission, supporting a protein-only agent model.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Prion diseases are fatal, transmissible neurological disorders affecting mammals.
- Evidence suggests the causative agent may be a pathogenic glycoprotein isoform, PrPsc, distinct from the normal PrPc.
- The prion protein gene (PrP) is linked to disease susceptibility.
Purpose of the Study:
- To review the role of transgenic technology in understanding prion disease biology.
- To discuss the evidence supporting a protein-only model for the prion disease agent.
Main Methods:
- Utilizing transgenic technology to study prion protein function and disease.
- Analyzing biochemical and genetic evidence implicating PrPsc.
- Examining PrP gene-ablated and mutated mouse models.
Main Results:
- PrP gene-ablated mice exhibit resistance to scrapie infection.
- Mice with specific PrP mutations develop spontaneous, transmissible prion diseases.
- Transgenic models have been crucial in elucidating prion disease mechanisms.
Conclusions:
- Transgenic technology has provided critical insights into prion disease pathogenesis.
- The prion protein (PrP) plays a central role, supporting a protein-only agent hypothesis.
- Further research using transgenic approaches is essential for understanding and combating prion diseases.
